Cannell & Spears LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1426319 NEW YORK, NY

Position in VRTX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$976,571

+$91,083 QoQ

Shares Held

1,966

-0.9% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#864

of 1,746 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cannell & Spears LLC holds $44,689,983 across 5 Biotechnology names. VRTX ranks #3 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	36,099	$22,509,170
2	AXSM	Axsome Therapeutics, Inc.	84,154	$20,598,374
3	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,966	$976,571
4	FTRE	Fortrea Holdings Inc.	31,315	$544,881
5	ALEC	Alector, Inc.	30,342	$60,987

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$976,571	1,966	-0.9%	Shares	Sole	2026-08-11
2026-03-31	$885,488	1,983	+1.2%	Shares	Sole	2026-05-15
2025-12-31	$888,585	1,960	0.0%	Shares	Sole	2026-02-17
2025-09-30	$767,614	1,960	+4.7%	Shares	Sole	2025-11-14
2025-06-30	$833,414	1,872	-1.9%	Shares	Sole	2025-08-14
2025-03-31	$925,521	1,909	-1.6%	Shares	Sole	2025-05-14
2024-12-31	$781,640	1,941	+0.2%	Shares	Sole	2025-02-12
2024-09-30	$901,325	1,938	-9.7%	Shares	Sole	2024-11-12
2024-06-30	$1,006,341	2,147	-15.0%	Shares	Sole	2024-08-12
2024-03-31	$1,056,311	2,527	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.